Related Articles
Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients.
Efficacy analysis of immunotherapy‑based combinations for patients with EGFR‑mutant advanced non‑small cell lung cancer after TKI failure
Nucleotide excision repair gene polymorphisms and prognosis of non?small cell lung cancer patients receiving platinum?based chemotherapy: A meta?analysis based on 44 studies
Association between CD4<sup>+</sup> T cells ATP levels and disease progression in patients with non‑small cell lung cancer
Efficacy and safety of camrelizumab (a PD‑1 inhibitor) combined with chemotherapy as a neoadjuvant regimen in patients with locally advanced non‑small cell lung cancer